High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: a randomized, phase 2, crossover trial.

Hansen, Kristoffer S; Mogensen, Trine H; Agergaard, Jane; Schiøttz-Christensen, Berit; Østergaard, Lars; Vibholm, Line K; Leth, Steffen

Hansen, Kristoffer S; Mogensen, Trine H; Agergaard, Jane; Schiøttz-Christensen, Berit; Østergaard, Lars; Vibholm, Line K; Leth, Steffen.

Afiliación

Hansen KS; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
Mogensen TH; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Agergaard J; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
Schiøttz-Christensen B; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Østergaard L; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
Vibholm LK; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
Leth S; Department of Regional Health Research, University of Southern Denmark, Odense, Denmark.

Lancet Reg Health Eur ; 24: 100539, 2023 Jan.

Article en En | MEDLINE | ID: mdl-36337437

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Lancet Reg Health Eur Año: 2023 Tipo del documento: Article País de afiliación: Dinamarca Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google